Kamel, Rima
64  Ergebnisse:
Personensuche X
?
2

Cardiac gene therapy with PDE2A limits ventricular remodeli..:

Kamel, Rima ; Bourcier, Aurélia ; Margaria, Jean Piero...
Archives of Cardiovascular Diseases Supplements.  14 (2022)  2 - p. 180 , 2022
 
?
3

Beneficial effects of a cardiac gene therapy with phosphodi..:

Kamel, Rima ; Bourcier, Aurélia ; Margaria, Jean Piero...
Journal of Molecular and Cellular Cardiology.  173 (2022)  - p. S45 , 2022
 
?
8

Cyclic nucleotide phosphodiesterases as therapeutic targets..:

Kamel, Rima ; Leroy, Jérôme ; Vandecasteele, Grégoire.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41569-022-00756-z.  , 2023
 
?
9

Cyclic nucleotide phosphodiesterases as therapeutic targets..:

Kamel, Rima ; Leroy, Jérôme ; Vandecasteele, Grégoire.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41569-022-00756-z.  , 2023
 
?
10

Cyclic nucleotide phosphodiesterases as therapeutic targets..:

Kamel, Rima ; Leroy, Jérôme ; Vandecasteele, Grégoire.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41569-022-00756-z.  , 2023
 
?
11

DRP1 haploinsufficiency attenuates cardiac ischemia/reperfu..:

Bouche, Laura ; Kamel, Rima ; Tamareille, Sophie...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0248554.  , 2021
 
?
12

DRP1 haploinsufficiency attenuates cardiac ischemia/reperfu..:

Bouche, Laura ; Kamel, Rima ; Tamareille, Sophie...
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0248554.  , 2021
 
?
 
1-15